Calcium channel blocker verapamil accelerates gambogic acid-induced cytotoxicity via enhancing proteasome inhibition and ROS generation.

[1]  Q. Dou,et al.  Gambogic Acid Induces Apoptosis in Imatinib-Resistant Chronic Myeloid Leukemia Cells via Inducing Proteasome Inhibition and Caspase-Dependent Bcr-Abl Downregulation , 2013, Clinical Cancer Research.

[2]  Jinbao Liu,et al.  Gambogic acid moderates cardiac responses to chronic hypoxia likely by acting on the proteasome and NF-κB pathway. , 2013, American journal of cardiovascular disease.

[3]  Q. Dou,et al.  Gambogic acid is a tissue-specific proteasome inhibitor in vitro and in vivo. , 2013, Cell reports.

[4]  Bing Li,et al.  L-Carnitine Is an Endogenous HDAC Inhibitor Selectively Inhibiting Cancer Cell Growth In Vivo and In Vitro , 2012, PloS one.

[5]  Michael L. Wang,et al.  Verapamil synergistically enhances cytotoxicity of bortezomib in mantle cell lymphoma via induction of reactive oxygen species production , 2012, British journal of haematology.

[6]  Di Chen,et al.  Gambogic acid enhances proteasome inhibitor-induced anticancer activity. , 2011, Cancer letters.

[7]  Q. Dou,et al.  Physiological levels of ATP negatively regulate proteasome function , 2010, Cell Research.

[8]  U. Schlötzer-Schrehardt,et al.  Calcium Channel Blocker Verapamil Enhances Reticulum Stress and Death Induced by Proteasome Inhibition in Myeloma Cells , 2010 .

[9]  Qing Zhao,et al.  Gambogic acid down-regulates MDM2 oncogene and induces p21(Waf1/CIP1) expression independent of p53. , 2009, Cancer letters.

[10]  Q. Dou,et al.  Clinical development of novel proteasome inhibitors for cancer treatment , 2009, Expert opinion on investigational drugs.

[11]  J. Tao,et al.  Gambogic acid induces apoptosis by regulating the expression of Bax and Bcl‐2 and enhancing caspase‐3 activity in human malignant melanoma A375 cells , 2009, International journal of dermatology.

[12]  Mingyao Liu,et al.  Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling. , 2008, Cancer research.

[13]  B. Aggarwal,et al.  Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-kappaB signaling pathway. , 2007, Blood.

[14]  Yong Yang,et al.  Differential apoptotic induction of gambogic acid, a novel anticancer natural product, on hepatoma cells and normal hepatocytes. , 2007, Cancer letters.

[15]  M. Munsell,et al.  NPI-0052, a novel proteasome inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and in combination with HDAC inhibitors in leukemia cells. , 2007, Blood.

[16]  A. Panthong,et al.  Anti-inflammatory, analgesic and antipyretic activities of the extract of gamboge from Garcinia hanburyi Hook f. , 2007, Journal of ethnopharmacology.

[17]  Hai-wei Zhang,et al.  Gambogic acid-induced G2/M phase cell-cycle arrest via disturbing CDK7-mediated phosphorylation of CDC2/p34 in human gastric carcinoma BGC-823 cells. , 2006, Carcinogenesis.

[18]  R. Pazdur,et al.  United States Food and Drug Administration Approval Summary: Bortezomib for the Treatment of Progressive Multiple Myeloma after One Prior Therapy , 2006, Clinical Cancer Research.

[19]  D. Green,et al.  A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Li Zhao,et al.  Anticancer effect and apoptosis induction of gambogic acid in human gastric cancer line BGC-823. , 2005, World journal of gastroenterology.

[21]  Cun-Yu Wang,et al.  Proteasome Inhibitor PS-341 Induces Apoptosis through Induction of Endoplasmic Reticulum Stress-Reactive Oxygen Species in Head and Neck Squamous Cell Carcinoma Cells , 2004, Molecular and Cellular Biology.

[22]  Q. You,et al.  Gambogic acid inhibits proliferation of human lung carcinoma SPC-A1 cells in vivo and in vitro and represses telomerase activity and telomerase reverse transcriptase mRNA expression in the cells. , 2004, Biological & pharmaceutical bulletin.

[23]  J. Adams.  The development of proteasome inhibitors as anticancer drugs. , 2004, Cancer cell.

[24]  Michael Butterworth,et al.  Caspase activation inhibits proteasome function during apoptosis. , 2004, Molecular cell.

[25]  E. Dees,et al.  The role of the ubiquitination-proteasome pathway in breast cancer: Applying drugs that affect the ubiquitin-proteasome pathway to the therapy of breast cancer , 2002, Breast Cancer Research.

[26]  T. Aw,et al.  Gadd153 Sensitizes Cells to Endoplasmic Reticulum Stress by Down-Regulating Bcl2 and Perturbing the Cellular Redox State , 2001, Molecular and Cellular Biology.

[27]  F. Levi-Schaffer,et al.  Role of reactive oxygen species (ROS) in apoptosis induction , 2000, Apoptosis.

[28]  Q. Dou,et al.  Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[29]  E. Sausville,et al.  Proteasome inhibitors: a novel class of potent and effective antitumor agents. , 1999, Cancer research.

[30]  D. Green,et al.  Bax-induced Caspase Activation and Apoptosis via Cytochromec Release from Mitochondria Is Inhibitable by Bcl-xL* , 1999, The Journal of Biological Chemistry.

[31]  U. Fuhr,et al.  Verapamil and drug metabolism by the cytochrome P450 isoform CYP1A2 , 1992, European Journal of Clinical Pharmacology.

[32]  G. T. Huang.  Dental pulp and dentin tissue engineering and regeneration: advancement and challenge. , 2011, Frontiers in bioscience.

[33]  J. Endicott,et al.  The biochemistry of P-glycoprotein-mediated multidrug resistance. , 1989, Annual review of biochemistry.

[34]  H. Frauendorf,et al.  Der Hauptbestandteil des Guttiharzes. 1. Mitt.: Chemie des Gummigutts , 1962 .